The Dichotomous Effect of Thiamine Supplementation on Tumorigenesis: A Systematic Review

References

• Amorim MO, Vieira MM, Gonçalves IV, Rhana P, Rodrigues ALP. Breast cancer: tumoral metabolism ­reprogramming. Rev Médica Minas Gerais. 2018;28:e-1937.
   Google Scholar
• Kim S. New and emerging factors in tumorigenesis: an overview. Cancer Manag Res. 2015;7:225–39. doi:10.2147/CMAR.S47797
   PubMed Web of Science ®Google Scholar
• Gu Q, Li F, Ge S, Zhang F, Jia R, Fan X. CDC20 knockdown and acidic microenvironment collaboratively promote tumorigenesis through inhibiting autophagy and apoptosis. Mol Ther Oncolytics. 2020;17:94–106. doi:10.1016/j.omto.2020.03.015
   PubMedGoogle Scholar
• Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Heal. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-6
   PubMed Web of Science ®Google Scholar
• Person PO. warburg: ‘on the origin of cancer cells. Oral Surg, Oral Med Oral Pathol. 1957;10(4):412–421. doi:10.1016/0030-4220(57)90167-6
   Google Scholar
• Gehm PM, Tratado de oncologia. Sao Paulo: Atheneu; 2013.
   Google Scholar
• Lonsdale D, Marrs C. The potential of lipid soluble thiamine in the treatment of cancer. AIMS Biophys. 2020;7(1):17–26. doi:10.3934/biophy.2020002
   Google Scholar
• Cozzolino SMF, editor. Biodisponibilidade de nutrientes. Barueri: Manole; 2016.
   Google Scholar
• Boros LG, Brandes JL, Lee WN, Cascante M, Puigjaner J, Revesz E, Bray TM, Schirmer WJ, Melvin WS. Thiamine supplementation to cancer patients: a double edged sword. Anticancer Res. 1998;18(1B):595–602.
   PubMedGoogle Scholar
• Zastre JA, Hanberry BS, Sweet RL, McGinnis AC, Venuti KR, Bartlett MG, Govindarajan R. Up-regulation of vitamin B1 homeostasis genes in breast cancer. J Nutr Biochem. 2013;24(9):1616–1624. doi:10.1016/j.jnutbio.2013.02.002
   PubMedGoogle Scholar
• Pourhassan M, Angersbach B, Lueg G, Klimek CN, Wirth R. Blood thiamine level and cognitive function in older hospitalized patients. J Geriatr Psychiatry Neurol. 2019;32(2):90–96. doi:10.1177/0891988718819862
   PubMedGoogle Scholar
• Champe PC. Bioquímica Ilustrada. Porto Alegre: Artmed; 2006.
   Google Scholar
• Lonsdale D. A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. Evid-Based Complem Alternat Med. 2006;3(1):49–59. doi:10.1093/ecam/nek009
   PubMed Web of Science ®Google Scholar
• Brasileiro FG. Patologia. 9th ed. Rio de Janeiro: Guanabara Koogan; 2016.
   Google Scholar
• Kumar V, Abbas A, Fausto N. Bases Patológica das Doenças. Rio de Janeiro: Elsevier; 2016.
   Google Scholar
• Galluzzi L, Kepp O, Heiden MGV, Kroemer G. Metabolic targets for cancer therapy. Nat Rev Drug Discov. 2013;12(11):829–846. doi:10.1038/nrd4145
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85–95. doi:10.1038/nrc2981
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. doi:10.1016/S0092-8674(00)81683-9
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. [Database] doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Remedios AA, Cutiño MP, Pérez Zv, Pérez Av. Papel de la reprogramación metabólica en la carcinogénesis. Correo Científico Médico. 2016;20(2):292–304.
   Google Scholar
• Harvey RA, Ferrier DR. Bioquímica Ilustrada. Porto Alegre: Artmed; 2019.
   Google Scholar
• Nelson D. Princípios de Bioquímica de Lehninger. 6th ed. São Paulo: Artmed; 2014.
   Google Scholar
• Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s achilles’ heel. Cancer Cell. 2008;13(6):472–482. doi:10.1016/j.ccr.2008.05.005
   PubMed Web of Science ®Google Scholar
• Wojtczak L. The Crabtree effect: A new look at the old problem. Acta Biochim Pol. 1996;43(2):361–368. doi:10.18388/abp.1996_4505
   PubMedGoogle Scholar
• Dell’ Antone P. Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects? Med Hypoth. 2012;79(3):388–392. doi:10.1016/j.mehy.2012.06.002
   PubMedGoogle Scholar
• Warbug O, Posener K, Negelein E. On the metabolism of carcinoma cells. Biochemische Zeitschrift. 1924;152:309–44.
   Google Scholar
• Kalyanaraman B. Teaching the basics of cancer metabolism: developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism. Redox Biol. 2017;12:833–842. doi:10.1016/j.redox.2017.04.018
   PubMed Web of Science ®Google Scholar
• Vernieri C, Casola S, Foiani M, Pietrantonio F, de Braud F, Longo V. Targeting cancer metabolism: dietary and pharmacologic interventions. Cancer Discov. 2016;6(12):1315–1333. doi:10.1158/2159-8290.CD-16-0615
   PubMed Web of Science ®Google Scholar
• Peck B, Schulze A. Lipid desaturation - the next step in targeting lipogenesis in cancer? Febs J. 2016;283(15):2767–2778. doi:10.1111/febs.13681
   PubMedGoogle Scholar
• Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle. 2020;11(2):366–380. doi:10.1002/jcsm.12525
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495. doi:10.1016/S1470-2045(10)70218-7
   PubMed Web of Science ®Google Scholar
• Argilés JM, Alvarez B, López-Soriano FJ. The metabolic basis of cancer cachexia. Med Res Rev. 1997;17(5):477–498. doi:10.1002/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.0.CO;2-R
   PubMed Web of Science ®Google Scholar
• Tisdale MJ. Cancer cachexia. Curr Opin Gastroenterol. 2010;26(2):146–151. doi:10.1097/MOG.0b013e3283347e77
   PubMed Web of Science ®Google Scholar
• Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, Blackwell K, Rimer BK. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. JCO. 2001;19(9):2381–2389. doi:10.1200/JCO.2001.19.9.2381
   PubMed Web of Science ®Google Scholar
• Brown JC, Caan BJ, Meyerhardt JA, Weltzien E, Xiao J, Cespedes Feliciano EM, Kroenke CH, Castillo A, Kwan ML, Prado CM. The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS). J Cachexia Sarcopenia Muscle. 2018;9(4):664–672. doi:10.1002/jcsm.12305
   PubMed Web of Science ®Google Scholar
• Wallengren O, Lundholm K, Bosaeus I. Diagnostic criteria of cancer cachexia: Relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer. 2013;21(6):1569–1577. doi:10.1007/s00520-012-1697-z
   PubMed Web of Science ®Google Scholar
• Camargo RG, Quintas Teixeira Ribeiro H, Geraldo MV, Matos-Neto E, Neves RX, Carlos Carnevali L, Donatto FF, Alcântara PSM, Ottoch JP, Seelaender M. Cancer cachexia and MicroRNAs. Mediat Inflamm. 2015;2015:1–5. doi:10.1155/2015/367561
   Google Scholar
• Argilés JM, Busquets S, López-Soriano FJ. Cytokines as mediators and targets for cancer cachexia. In: Dalgleish AG, Haefner B, editors. The link between inflammation and cancer. Vol. 130. Boston (MA): Springer; 2006. p. 199–217.
   Google Scholar
• Tisdale MJ. The ‘cancer cachectic factor’. Support Care Cancer. 2003;11(2):73–78. doi:10.1007/s00520-002-0408-6
   PubMedGoogle Scholar
• McMillan D. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer: Nutrition Society and BAPEN Medical Symposium on ‘Nutrition support in cancer therapy. Proc Nutr Soc. 2008;67(3):257–262. doi:10.1017/S0029665108007131
   PubMed Web of Science ®Google Scholar
• Goldman MDL, Bennet MDJ. Tratado de medicina interna. Rio de Janeiro: Guanabara Koogan; 2001.
   Google Scholar
• Mahan K, Scott-Stump S. Krause alimentos, nutrição e dietoterapia. São Paulo: Roca; 2002.
   Google Scholar
• Murad A, Katz A. Oncologia bases clínicas do tratamento. Rio de Janeiro: Guanabara Koogan; 1996.
   Google Scholar
• Silva MPN. Síndrome da anorexia-caquexia em portadores de câncer. Rev Bras Cancerol. 2006; 52(1):59–7. doi:10.32635/2176-9745.RBC.2006v52n1.1910
   Google Scholar
• Hauner H, Petruschke T, Russ M, Röhrig K, Eckel J. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia. 1995;38(7):764–771. doi:10.1007/s001250050350
   PubMed Web of Science ®Google Scholar
• Mattox TW. Cancer cachexia: cause, diagnosis, and treatment. Nutr Clin Pract. 2017;32(5):599–606. doi:10.1177/0884533617722986
   PubMedGoogle Scholar
• Watters JM, Bessey PQ, Dinarello CA, Wolff SM, Wilmore DW. Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg. 1986;121(2):179–190. doi:10.1001/archsurg.1986.01400020065008
   PubMedGoogle Scholar
• Burt ME, Aoki TT, Gorschboth CM, Brennan MF. Peripheral tissue metabolism in cancer-bearing man. Ann Surg. 1983;198(6):685–691. doi:10.1097/00000658-198312000-00003
   PubMedGoogle Scholar
• Rohdenburg GL, Bernhard A, Krehbiel O. Sugar tolerance in cancer. JAMA. 1919;72(21):1528–1530. doi:10.1001/jama.1919.02610210024007
   Google Scholar
• Bishop JS, Marks PA. Studies on carbohydrate metabolism in patients with neoplastic disease. II. Response to insulin administration. J Clin Invest. 1959;38(4):668–672. doi:10.1172/JCI103845
   PubMedGoogle Scholar
• Petruzzelli M, Wagner EF. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev. 2016;30(5):489–501. doi:10.1101/gad.276733.115
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Heber D. Metabolic abnormalities in cancer patients: Carbohydrate metabolism. Surg Clin North Am. 1986;66(5):957–968. doi:10.1016/s0039-6109(16)44035-1
   PubMedGoogle Scholar
• Das SK, Hoefler G. The role of triglyceride lipases in cancer associated cachexia. Trends Mol Med. 2013;19(5):292–301. doi:10.1016/j.molmed.2013.02.006
   PubMedGoogle Scholar
• Young SG, Zechner R. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev. 2013;27(5):459–484. doi:10.1101/gad.209296.112
   PubMed Web of Science ®Google Scholar
• Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, Gorkiewicz G, Tamilarasan KP, Kumari P, Trauner M, et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science. 2011;333(6039):233–238. doi:10.1126/science.1198973
   PubMed Web of Science ®Google Scholar
• Tisdale MJ. Pathogenesis of cancer cachexia. J Support Oncol. 2003;1(3):159–168.
   PubMedGoogle Scholar
• Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol - Endocrinol Metab. 1993;264(4):27–4.
   Google Scholar
• Mitch WE, Medina R, Grieber S, May RC, England BK, Price SR, Bailey JL, Goldberg AL. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest. 1994;93(5):2127–2133. doi:10.1172/JCI117208
   PubMedGoogle Scholar
• Temparis S, Asensi M, Taillandier D, Aurousseau E, Larbaud D, Obled A. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res. 1994;54(21):5568–73.
   PubMedGoogle Scholar
• Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E 2 release by leukocytic pyrogen (interleukin-1). N Engl J Med. 1983;308(10):553–558. doi:10.1056/NEJM198303103081002
   PubMed Web of Science ®Google Scholar
• Trebukhina RV, Ostrovsky YM, Shapot VS, Mikhaltsevich GN, Tumanov VN. Turnover of [14C]thiamin and activities of thiamin pyrophosphate-dependent enzymes in tissues of mice with ehrlich ascites carcinoma. Nutr Cancer. 1985;6(4):260–273. doi:10.1080/01635588509513832
   Google Scholar
• Cascante M, Centelles JJ, Veech RL, Lee WN, Boros LG. Role of thiamin (vitamin B-1) and transketolase in tumor cell proliferation. Nutr Cancer. 2000;36(2):150–154. doi:10.1207/S15327914NC3602_2
   PubMed Web of Science ®Google Scholar
• Hathurusinghe HR, Goonetilleke KS, Siriwardena AK. Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy. Ann Surg Oncol. 2007;14(10):2714–2720. doi:10.1245/s10434-007-9481-x
   PubMedGoogle Scholar
• Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 2011;334(6060):1278–1283. doi:10.1126/science.1211485
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104(49):19345–19350. doi:10.1073/pnas.0709747104
   PubMed Web of Science ®Google Scholar
• Jonus HC, Byrnes CC, Kim J, Valle ML, Bartlett MG, Said HM, Zastre JA. Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy. Biomed Pharmacother. 2020;121(109648):109648. doi:10.1016/j.biopha.2019.109648
   PubMedGoogle Scholar
• Liu S, Huang H, Lu X, Golinski M, Comesse S, Watt D, Grossman RB, Moscow JA. Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol Cancer Res. 2003;1(9):665–673.
   PubMedGoogle Scholar
• Liu X, Lam EKY, Wang X, Zhang J, Cheng YY, Lam YW, Ng EKO, Yu J, Chan FKL, Jin H, et al. Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer. Tumour Biol. 2009;30(5-6):242–248. doi:10.1159/000243767
   PubMed Web of Science ®Google Scholar
• Ikehata M, Ueda K, Iwakawa S. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines. Biol Pharm Bull. 2012;35(3):301–307. doi:10.1248/bpb.35.301
   PubMedGoogle Scholar
• Kim S, Rhee J-k, Yoo HJ, Lee HJ, Lee EJ, Lee JW, Yu JH, Son BH, Gong G, Kim SB, et al. Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer. Cancer Lett. 2015;357(2):488–497. doi:10.1016/j.canlet.2014.11.058
   PubMedGoogle Scholar
• Grabowska E, Czerniecka M, Czyżewska U, Zambrzycka A, Łotowski Z, Tylicki A. Differences in the efficiency of 3-deazathiamine and oxythiamine pyrophosphates as inhibitors of pyruvate dehydrogenase complex and growth of HeLa cells in vitro. J Enzyme Inhib Med Chem. 2021;36(1):122–129. doi:10.1080/14756366.2020.1844681
   PubMed Web of Science ®Google Scholar
• Grimm M, Calgéer B, Teriete P, Biegner T, Munz A, Reinert S. Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma? Clin Transl Oncol. 2016;18(2):196–205. doi:10.1007/s12094-015-1352-5
   PubMedGoogle Scholar
• Boros LG. Population thiamine status and varying cancer rates between western, Asian and African countries. Anticancer Res. 2000;20(3B):2245–2248.
   PubMedGoogle Scholar
• Cancarini I, Krogh V, Agnoli C, Grioni S, Matullo G, Pala V, Pedraglio S, Contiero P, Riva C, Muti P, et al. Micronutrients involved in one-carbon metabolism and risk of breast cancer subtypes. PLoS One. 2015;10(9):e0138318. doi:10.1371/journal.pone.0138318
   PubMed Web of Science ®Google Scholar
• Curto-García N, Harrison CN, McLornan DP, Radia DH. Thiamine deficiency appears uncommon in patients with myeloproliferative neoplasms. Br J Haematol. 2017;178(2):338–340. doi:10.1111/bjh.14128
   PubMed Web of Science ®Google Scholar
• Arthur RS, Kirsh VA, Rohan TE. Dietary B-vitamin intake and risk of breast, endometrial, ovarian and colorectal cancer among Canadians. Nutr Cancer. 2019;71(7):1067–1077. doi:10.1080/01635581.2019.1597904
   PubMed Web of Science ®Google Scholar
• Shiao SPK, Grayson J, Lie A, Yu CH. Personalized nutrition-genes, diet, and related interactive parameters as predictors of cancer in multiethnic colorectal cancer families. Nutrients. 2018;10(6):795. doi:10.3390/nu10060795
   PubMed Web of Science ®Google Scholar
• Lee BY, Yanamandra K, Bocchini JA. Jr. Thiamin deficiency: a possible major cause of some tumors? (review). Oncol Rep. 2005;14(6):1589–1592.
   PubMedGoogle Scholar
• Isenberg-Grzeda E, Shen MJ, Alici Y, Wills J, Nelson C, Breitbart W. High rate of thiamine deficiency among inpatients with cancer referred for psychiatric consultation: results of a single site prevalence study. Psychooncology. 2017;26(9):1384–1389. doi:10.1002/pon.4155
   PubMed Web of Science ®Google Scholar
• Kikut J, Jasińska A, Pobłocki J, Brodowski J, Małgorzata S. Assessment and state of nutrition of patients with gastroenteropancreatic neuroendocrine neoplasms. Nutrients. 2020;12(7):1961. doi:10.3390/nu12071961
   PubMedGoogle Scholar
• Egnell M, Fassier P, Lécuyer L, Zelek L, Vasson MP, Hercberg S, Latino-Martel P, Galan P, Deschasaux M, Touvier M. B-vitamin intake from diet and supplements and breast cancer risk in middle-aged women: results from the prospective NutriNet-Santé cohort. Nutrients. 2017;9(5):488. doi:10.3390/nu9050488
   PubMedGoogle Scholar
• Dugué PA, Bassett JK, Brinkman MT, Southey MC, Joo JE, Wong EM, Milne RL, English DR, Giles GG, Boussioutas A, Mitchell H, et al. Dietary intake of nutrients involved in one-carbon metabolism and risk of gastric cancer: a prospective study. Nutr Cancer. 2019;71(4):605–614. doi:10.1080/01635581.2019.1577982
   PubMed Web of Science ®Google Scholar
• Gangat N, Phelps A, Lasho TL, Finke CM, Vallapureddy R, Hanson CA, et al. A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy. Blood Cancer J. 2019;9(2):9–12.
   PubMedGoogle Scholar
• Nesterova VI, Chebotareva MA. Thiamine content and enzyme activity in blood cells in leukemia. Vopr Med Khim. 1976;22(6):732–735.
   PubMedGoogle Scholar
• Sheline CT. Thiamine supplementation attenuated hepatocellular carcinoma in the Atp7b mouse model of Wilson’s disease. Anticancer Res. 2011;31(10):3395–3399.
   PubMedGoogle Scholar
• Gevorkyan L, Gambashidze K. Anticancer efficacy of hydroxyethylthiamine diphosphate in vivo. Exp Oncol. 2014;36(1):48–9.
   PubMedGoogle Scholar
• Hanberry BS, Berger R, Zastre JA. High-dose vitamin B1 reduces proliferation in cancer cell lines analogous to dichloroacetate. Cancer Chemother Pharmacol. 2014;73(3):585–594. doi:10.1007/s00280-014-2386-z
   PubMedGoogle Scholar
• Liu X, Montissol S, Uber A, et al. The effects of thiamine on breast cancer cells. Molecules. 2018;23(6):1464.
   PubMedGoogle Scholar
• Afzal M, Kazmi I, Khan R, Rana P, Kumar V, Al-Abbasi FA, Zamzami MA, Anwar F. Thiamine potentiates chemoprotective effects of ibuprofen in DEN induced hepatic cancer via alteration of oxidative stress and inflammatory mechanism. Arch Biochem Biophys. 2017;623-624:58–63. doi:10.1016/j.abb.2017.05.006
   PubMed Web of Science ®Google Scholar
• Tiwana GS, Prevo R, Buffa FM, Yu S, Ebner DV, Howarth A, Folkes LK, Budwal B, Chu KY, Durrant L, et al. Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen. Oncotarget. 2015;6(8):5978–5989. doi:10.18632/oncotarget.3468
   PubMedGoogle Scholar
• Wang J, Zhang X, Ma D, Lee W-NP, Xiao J, Zhao Y, Go VL, Wang Q, Yen Y, Recker R, et al. Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells. Exp Hematol Oncol. 2013;2(1):18. doi:10.1186/2162-3619-2-18
   PubMedGoogle Scholar
• Lu H, Lan WX, Bo L, Niu C, Zhou JJ, Zhu HL. Metabolic response of LLC xenografted mice to oxythiamine, as measured by [1H] NMR spectroscopy. Genet Mol Res. 2015;14(3):11043–11051. doi:10.4238/2015.September.21.17
   PubMedGoogle Scholar
• Sugimori N, Espinoza JL, Trung LQ, Takami A, Kondo Y, An DT, Sasaki M, Wakayama T, Nakao S. Paraptosis cell death induction by the thiamine analog benfotiamine in leukemia cells. Mills K, organizador. PLoS One. 2015;10(4):e0120709. doi:10.1371/journal.pone.0120709
   PubMedGoogle Scholar